Jiang Zhu

14PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Dec 30, 2025
A randomized, controlled, multicenter phase III clinical trial of Huo Xiang Zheng Qi oral liquid for the prevention and control of nausea and vomiting caused by multiday cisplatin-based regimen.

Liping Tong, Songze Wu, Zixuan Ye

|May 13, 2024
Evaluating Oral Probiotic Supplements as Complementary Treatment in Advanced Lung Cancer Patients Receiving ICIs: A Prospective Real-World Study.

Liping Tong, Yuming Wan, Xiaoxiao Shi

|Nov 29, 2023
Oral compound probiotic supplements can improve the quality of life for patients with lung cancer during chemotherapy: A randomized placebo-controlled study.

Hao Wei, Zhiying Yue, Jialong Han

|Aug 15, 2023
Safety and Tolerability of Low-Dose Radiation and Stereotactic Body Radiotherapy + Sintilimab for Treatment-Naïve Stage IV PD-L1+ Non-Small Cell Lung Cancer Patients.

Xiaojuan Zhou, Laiyan Zhou, Zhuoran Yao

|Apr 13, 2023
Immunotherapy vs. Chemotherapy in Subsequent Treatment of Malignant Pleural Mesothelioma: Which Is Better?

Xiaotong Guo, Lede Lin, Jiang Zhu

|Mar 31, 2023
Huo Xiang Zheng Qi Oral Liquid Combined with 5-HT3 Receptor Antagonists and Dexamethasone Can Prevent Chemotherapy-Induced Nausea and Vomiting for Patients Receiving Multiday Cisplatin-Based Regimen: A Multicenter Trial.

Hao Wei, Yu Sun, Lingling Xie

Pageof 3

Frequent Collaborators

2 joint publications

Bingwen Zou

2 joint publications

Yanying Li

2 joint publications

Yu Sun

2 joint publications

Hao Wei